Laboratory of Bacteriology and Bioassays (LaBBio), Department of Microbiology and Parasitology, Biology Institute, Federal University of Pelotas, Pelotas, RS, Brazil.
J Med Microbiol. 2021 Nov;70(11). doi: 10.1099/jmm.0.001451.
A significant cause of mortality in the intensive care unit (ICU) is multidrug-resistant (MDR) Gram-negative bacteria, such as carbapenemase (KPC). Biofilm production is a key factor in KPC colonization and persistence in the host, making the treatment difficult. The aim of this study was to evaluate the antibiotic resistance, molecular and phenotypic biofilm profiles of 12 KPC isolates associated with nosocomial infection in a hospital in Pelotas, Rio Grande do Sul, Brazil. Clinical isolates were obtained from different sources, identified and characterized by antibiotic resistance and carbapenemase synthesis following the Clinical and Laboratory Standards Institute (CLSI) guidelines. Polymerase chain reaction (PCR) was used to evaluate the presence of carbapenemase () and biofilm formation-associated genes (, , , , and ). Additionally, phenotypic evaluation of biofilm formation capacity was evaluated by Congo red agar (CRA) assay and the crystal violet staining method. The 12 isolates evaluated in this study presented the gene and were positive for synthesizing carbapenemases . In the carbapenem class, 83.3 % isolates were resistant and 16.7 % intermediately resistant to imipenem and meropenem. Molecular analyses found that the and genes were detected in 75 % of isolates, while and were detected in 42 % and were detected in 8.3 % (1). The CRA assay demonstrated that all isolates were slime producers and 91.7 % (11) of isolates were classified as strong and 8.3 % (1) as moderate biofilm producers by the crystal violet staining method. The optical density (OD) for strong biofilm formers ranged from 0.80±0.05 to 2.47±0.28 and was 0.55±0.12 for moderate biofilm formers. Our study revealed a high level of antibiotic resistance and biofilm formation in KPC isolates obtained from a hospital in Pelotas, RS, Brazil.
巴西佩洛塔斯一家医院的 12 株与医院获得性感染相关的碳青霉烯酶(KPC)分离株的抗生素耐药性、分子和表型生物膜特征评估
重症监护病房(ICU)死亡率的一个重要原因是多药耐药(MDR)革兰氏阴性菌,如碳青霉烯酶(KPC)。生物膜的产生是 KPC 在宿主中定植和持续存在的关键因素,这使得治疗变得困难。本研究的目的是评估巴西佩洛塔斯(RS)一家医院获得性感染相关的 12 株 KPC 分离株的抗生素耐药性、分子和表型生物膜特征。临床分离株分别从不同来源获得,根据临床和实验室标准协会(CLSI)指南,通过抗生素耐药性和碳青霉烯酶合成来鉴定和特征分析。聚合酶链反应(PCR)用于评估碳青霉烯酶()和生物膜形成相关基因(、、、、和)的存在。此外,通过刚果红琼脂(CRA)试验和结晶紫染色法评估了表型生物膜形成能力。本研究评估的 12 株分离株均携带 基因,且均能合成碳青霉烯酶。在碳青霉烯类药物中,83.3%的分离株对亚胺培南和美罗培南耐药,16.7%的分离株中介耐药。分子分析发现,75%的分离株检测到 和 基因,42%的分离株检测到 基因,8.3%的分离株检测到 基因。CRA 试验表明,所有分离株均为黏液产生菌,结晶紫染色法将 91.7%(11 株)的分离株归类为强生物膜形成菌,8.3%(1 株)的分离株归类为中生物膜形成菌。强生物膜形成菌的光密度(OD)值范围为 0.80±0.05~2.47±0.28,中生物膜形成菌的 OD 值为 0.55±0.12。本研究显示,巴西佩洛塔斯一家医院分离的 KPC 分离株具有较高的抗生素耐药性和生物膜形成能力。